Literature DB >> 25129572

Treatment of PTSD and Chronic Daily Headache.

Todd A Smitherman1, Anna Katherine Black, Christal N Davis.   

Abstract

OPINION STATEMENT: Posttraumatic stress disorder (PTSD) is often comorbid with chronic migraine (CM) and chronic tension-type headache (CTTH). Trauma-focused cognitive behavioral psychotherapies, selective serotonin reuptake inhibitors (SSRIs), and venlafaxine have demonstrated efficacy in the treatment of PTSD. Amitriptyline, topiramate, sodium valproate, and botulinum toxin A are efficacious for treatment of chronic daily headache (CDH). Treatment studies on individuals with CDH and comorbid PTSD, however, are limited. As such, multiple therapeutic agents or modes of interventions typically are necessary, such that comprehensive treatment simultaneously utilizes approaches with established efficacy for each individual condition.

Entities:  

Year:  2014        PMID: 25129572     DOI: 10.1007/s11940-014-0312-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  66 in total

1.  Eye movement desensitization and reprocessing (EMDR): a meta-analysis.

Authors:  P R Davidson; K C Parker
Journal:  J Consult Clin Psychol       Date:  2001-04

2.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

3.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 4.  Behavioral headache treatment: history, review of the empirical literature, and methodological critique.

Authors:  Jeanetta C Rains; Donald B Penzien; Douglas C McCrory; Rebecca N Gray
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

5.  Predictors of post-traumatic headache severity among deployed military personnel.

Authors:  Craig J Bryan; Ann M Hernandez
Journal:  Headache       Date:  2011-04-01       Impact factor: 5.887

Review 6.  Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis.

Authors:  Jonathan I Bisson; Anke Ehlers; Rosa Matthews; Stephen Pilling; David Richards; Stuart Turner
Journal:  Br J Psychiatry       Date:  2007-02       Impact factor: 9.319

7.  Topiramate in the treatment of chronic migraine.

Authors:  M Silvestrini; M Bartolini; M Coccia; R Baruffaldi; R Taffi; L Provinciali
Journal:  Cephalalgia       Date:  2003-10       Impact factor: 6.292

8.  Childhood maltreatment and migraine (part I). Prevalence and adult revictimization: a multicenter headache clinic survey.

Authors:  Gretchen E Tietjen; Jan L Brandes; B Lee Peterlin; Arnolda Eloff; Rima M Dafer; Michael R Stein; Ellen Drexler; Vincent T Martin; Susan Hutchinson; Sheena K Aurora; Ana Recober; Nabeel A Herial; Christine Utley; Leah White; Sadik A Khuder
Journal:  Headache       Date:  2009-10-21       Impact factor: 5.887

9.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

10.  Depression and risk of transformation of episodic to chronic migraine.

Authors:  Sait Ashina; Daniel Serrano; Richard B Lipton; Morris Maizels; Aubrey N Manack; Catherine C Turkel; Michael L Reed; Dawn C Buse
Journal:  J Headache Pain       Date:  2012-09-25       Impact factor: 7.277

View more
  2 in total

Review 1.  Approach to chronic daily headache.

Authors:  Huma U Sheikh
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

2.  Integrative East-West Medicine Intervention for Chronic Daily Headache: A Case Report and Care Perspective.

Authors:  Justin G Laube; Thais Salles Araujo; Lawrence B Taw
Journal:  Glob Adv Health Med       Date:  2020-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.